logo

For the Inventor, By the Inventor

Plymouth Meeting, PA, United States of America

Vgx Pharmaceuticals, Inc.


USPTO Granted Patents = 18



Trademarks = 3

Forward Citations = 195

Loading Chart...
Loading Chart...

31 inventors (with patents filed for the assignee):

goldMedal Ruxandra Draghia-Akli (14 out of 28 patents)

silverMedal Amir S Khan (5 out of 10 patents)

bronzeMedal Douglas R Kern (4 out of 9 patents)

4.  Patricia A Brown (3 out of 10 patents)

5.  Mathura P Ramanathan (3 out of 14 patents)

6.  Robert Hunt Carpenter (3 out of 28 patents)

7.  Niranjan Y Sardesai (3 out of 30 patents)

8.  Melissa Pope (3 out of 3 patents)

9.  William R Wilkinson (1 out of 25 patents)

10.  Jian Yan (1 out of 71 patents)

11.  Kate Broderick (1 out of 20 patents)

12.  Karuppiah Muthumani (1 out of 30 patents)

13.  Bernadette Ferraro (1 out of 12 patents)

14.  Rodney A Bowling (1 out of 4 patents)

15.  Rune Kjeken (1 out of 7 patents)


18 patents:

1. 10294278 - Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom (2019-05-21),
2. 10232173 - Contactless electropermeabilization electrode and method (2019-03-19),
3. 9452285 - Electroporation devices and methods of using same for electroporation of cells in mammals (2016-09-27),
4. 8962818 - Compositions comprising GHRH and GnRH and methods of using the same (2015-02-24),
5. 8961994 - DNA constructs eliciting immune response against flavivirus and effective adjuvants (2015-02-24),
6. 8927508 - Antibody production elicited by a DNA vaccine delivered by electroporation (2015-01-06),
7. 8835620 - Vaccines against multiple subtypes of dengue virus (2014-09-16),
8. 8563302 - Optimized high yield synthetic plasmids (2013-10-22),
9. 8481504 - Insulin-like growth factor (IGF-I) plasmid-mediated supplementation for therapeutic applications (2013-07-09),
10. 8209006 - Constant current electroporation device and methods of use (2012-06-26),
11. 8188056 - Reducing arthritis and lameness in subjects by growth hormone releasing hormone (GHRH) supplementation (2012-05-29),
12. 8178504 - Gene therapy expression of GHRH for increasing RBC count in subjects (2012-05-15),
13. 8058253 - Growth hormone releasing hormone treatment to decrease cholesterol levels (2011-11-15),
14. 7846720 - Optimized high yield synthetic plasmids (2010-12-07),
15. 7664545 - Electrode assembly for constant-current electroporation and use (2010-02-16),
VGX Pharmaceuticals, Inc. is a leading biotechnology company specializing in the development and delivery of advanced gene therapies. Our goal is to revolutionize the treatment of genetic diseases through innovative genetic engineering techniques. With a strong focus on research and development, we are committed to bringing cutting-edge therapies to patients in need. Visit our website to learn more about our groundbreaking advancements in gene therapy.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Jan 20 2026

18 Patents

#6 in Plymouth Meeting, PA

#652 in Pennsylvania

#17,439 in US

#33,250 in the World

...
Plymouth Meeting, PA, United States of America

Vgx Pharmaceuticals, Inc.

Forward Citations = 195

31 inventors:

goldMedal Ruxandra Draghia-Akli (14 out of 28 patents)

silverMedal Amir S Khan (5 out of 10 patents)

bronzeMedal Douglas R Kern (4 out of 9 patents)

4.  Patricia A Brown (3 out of 10 patents)

5.  Mathura P Ramanathan (3 out of 14 patents)

Please report any incorrect information to support@idiyas.com
Loading…